Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:INSW NASDAQ:REGN NYSE:RLI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINSWInternational Seaways$83.62-1.7%$77.49$35.60▼$92.66$4.21B-0.09620,223 shs620,150 shsREGNRegeneron Pharmaceuticals$638.88-0.6%$731.45$476.49▼$821.11$67.93B0.31.01 million shs994,824 shsRLIRLI$52.56-0.9%$55.48$47.26▼$77.24$4.87B0.421.06 million shs524,094 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINSWInternational Seaways-1.89%-1.12%+9.72%+24.09%+122.92%REGNRegeneron Pharmaceuticals-0.58%-8.50%-14.43%-18.06%+5.67%RLIRLI-0.87%+3.30%-8.24%-13.71%-29.31%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINSWInternational Seaways$83.62-1.7%$77.49$35.60▼$92.66$4.21B-0.09620,223 shs620,150 shsREGNRegeneron Pharmaceuticals$638.88-0.6%$731.45$476.49▼$821.11$67.93B0.31.01 million shs994,824 shsRLIRLI$52.56-0.9%$55.48$47.26▼$77.24$4.87B0.421.06 million shs524,094 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINSWInternational Seaways-1.89%-1.12%+9.72%+24.09%+122.92%REGNRegeneron Pharmaceuticals-0.58%-8.50%-14.43%-18.06%+5.67%RLIRLI-0.87%+3.30%-8.24%-13.71%-29.31%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINSWInternational Seaways 2.71Moderate Buy$83.50-0.14% DownsideREGNRegeneron Pharmaceuticals 2.70Moderate Buy$792.6524.07% UpsideRLIRLI 2.29Hold$61.5017.01% UpsideCurrent Analyst Ratings BreakdownLatest INSW, REGN, and RLI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2026REGNRegeneron Pharmaceuticals Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$1,057.00 ➝ $875.005/18/2026INSWInternational Seaways Pareto SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold5/18/2026REGNRegeneron Pharmaceuticals BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$900.00 ➝ $730.005/18/2026REGNRegeneron Pharmaceuticals Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$796.00 ➝ $778.005/18/2026REGNRegeneron Pharmaceuticals JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$950.00 ➝ $850.005/18/2026REGNRegeneron Pharmaceuticals Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$762.00 ➝ $707.005/18/2026REGNRegeneron Pharmaceuticals Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$800.00 ➝ $700.005/18/2026REGNRegeneron Pharmaceuticals Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$875.00 ➝ $855.005/18/2026REGNRegeneron Pharmaceuticals CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral$900.00 ➝ $700.005/18/2026REGNRegeneron Pharmaceuticals Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform$792.00 ➝ $641.005/11/2026INSWInternational Seaways Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C+) ➝ Buy (B-)(Data available from 5/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINSWInternational Seaways$843.30M4.91$8.68 per share9.63$44.33 per share1.89REGNRegeneron Pharmaceuticals$14.34B4.71$41.73 per share15.31$297.23 per share2.15RLIRLI$1.88B2.57$3.55 per share14.80$19.54 per share2.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINSWInternational Seaways$309.26M$10.987.6211.30N/A55.39%21.04%15.60%8/5/2026 (Estimated)REGNRegeneron Pharmaceuticals$4.50B$41.0415.5715.371.4229.65%13.16%10.17%7/30/2026 (Estimated)RLIRLI$403.34M$4.2812.2819.54N/A20.81%17.72%5.13%7/20/2026 (Estimated)Latest INSW, REGN, and RLI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026INSWInternational Seaways$2.87$3.90+$1.03$5.75$279.34 million$325.48 million4/29/2026Q1 2026REGNRegeneron Pharmaceuticals$8.91$9.47+$0.56$6.75$3.48 billion$3.61 billion4/22/2026Q1 2026RLIRLI$0.7280$0.83+$0.1020$0.60$564.47 million$423.87 million2/26/2026Q4 2025INSWInternational Seaways$1.75$2.45+$0.70$2.56$245.29 million$267.88 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthINSWInternational Seaways$0.480.57%+64.94%4.37%N/AREGNRegeneron Pharmaceuticals$3.760.59%N/A9.16%N/ARLIRLI$0.641.22%+21.83%14.95%51 YearsLatest INSW, REGN, and RLI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2026INSWInternational Seawaysquarterly$0.120.53%6/12/20266/12/20266/26/20265/14/2026RLIRLIquarterly$0.181.44%5/29/20265/29/20266/12/20264/29/2026REGNRegeneron Pharmaceuticalsquarterly$0.940.58%5/20/20265/20/20266/4/20262/25/2026INSWInternational Seawaysquarterly$0.120.71%3/20/20263/20/20263/30/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINSWInternational Seaways0.267.347.28REGNRegeneron Pharmaceuticals0.063.572.96RLIRLIN/A0.370.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINSWInternational Seaways67.29%REGNRegeneron Pharmaceuticals83.31%RLIRLI77.89%Insider OwnershipCompanyInsider OwnershipINSWInternational Seaways1.70%REGNRegeneron Pharmaceuticals6.97%RLIRLI2.39%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINSWInternational Seaways2,76349.51 million48.66 millionOptionableREGNRegeneron Pharmaceuticals15,410105.72 million98.35 millionOptionableRLIRLI1,19391.94 million89.74 millionOptionableINSW, REGN, and RLI HeadlinesRecent News About These CompaniesWhy Is RLI Corp. (RLI) Down 3.5% Since Last Earnings Report?May 22 at 12:32 PM | zacks.comCB Boosts Shareholder Value With Dividends, Okays Buyback ProgramMay 22 at 11:26 AM | zacks.comRLI Corp.: A High-Quality Insurer Still Worth BuyingMay 21 at 5:50 PM | seekingalpha.comRLI Shareholders Back Board, Name New ChairmanMay 20 at 6:51 PM | tipranks.comInsider Buying: RLI (NYSE:RLI) COO Buys 2,000 Shares of StockMay 20 at 6:34 AM | insidertrades.comRLI (RLI) Shares Skyrocket, What You Need To KnowMay 19, 2026 | finance.yahoo.comProperty & Casualty Insurance Stocks Q1 Results: Benchmarking RLI (NYSE:RLI)May 19, 2026 | finance.yahoo.comChase Investment Counsel Corp Acquires New Stake in RLI Corp. $RLIMay 18, 2026 | marketbeat.comZacks Research Comments on RLI's Q2 Earnings (NYSE:RLI)May 18, 2026 | americanbankingnews.comZacks Research Issues Positive Forecast for RLI EarningsMay 18, 2026 | marketbeat.comThrivent Financial for Lutherans Has $65.37 Million Stock Position in RLI Corp. $RLIMay 16, 2026 | marketbeat.comGainsco (OTCMKTS:GANS) and RLI (NYSE:RLI) Head-To-Head AnalysisMay 16, 2026 | americanbankingnews.comRLI Boosts Shareholder Value With Dividends, Approves Buyback ProgramMay 15, 2026 | zacks.comAnalysts Set Expectations for RLI's Q4 Earnings (NYSE:RLI)May 15, 2026 | marketbeat.comYMIRLINK Sets Out Q1 2026 Results, Full‑Year Outlook and Growth PlanMay 14, 2026 | tipranks.comWhy is RLI stock rising today?May 14, 2026 | msn.comRLI (RLI) shares skyrocket. What you need to knowMay 14, 2026 | msn.comRLI Declares Regular and Special Dividends and Authorizes New $250 Million Share Repurchase ProgramMay 14, 2026 | finance.yahoo.comRLI Boosts Dividend and Authorizes New Share RepurchaseMay 14, 2026 | tipranks.comRLI Corp. (NYSE:RLI) Given Average Recommendation of "Hold" by BrokeragesMay 14, 2026 | americanbankingnews.comHere’s Why FPA Queens Road Small Cap Value Fund Increased Its Holdings in RLI Corp (RLI)May 12, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINSW, REGN, and RLI Company DescriptionsInternational Seaways NYSE:INSW$83.62 -1.49 (-1.75%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$83.62 +0.00 (+0.00%) As of 05/22/2026 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.International Seaways, Inc. owns and operates a fleet of oceangoing vessels for the transportation of crude oil and petroleum products in the international flag trade. It operates in two segments: Crude Tankers and Product Carriers. As of December 31, 2023, the company owned a fleet of 73 vessels. It serves independent and state-owned oil companies, oil traders, refinery operators, and international government entities. The company was formerly known as OSG International, Inc. and changed its name to International Seaways, Inc. in October 2016. International Seaways, Inc. was incorporated in 1999 and is headquartered in New York, New York.Regeneron Pharmaceuticals NASDAQ:REGN$638.88 -3.71 (-0.58%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$634.44 -4.44 (-0.69%) As of 05/22/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.RLI NYSE:RLI$52.56 -0.45 (-0.85%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$52.56 +0.01 (+0.01%) As of 05/22/2026 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.RLI Corp., an insurance holding company, underwrites property and casualty insurance. Its Casualty segment provides commercial and personal coverage products; and general liability products, such as coverage for third-party liability of commercial insureds, including manufacturers, contractors, apartments, and mercantile. It also offers coverages for security guards and environmental liability for underground storage tanks, contractors and asbestos, and environmental remediation specialists; and professional liability coverages for errors and omission coverage for small to medium-sized design, technical, computer, and miscellaneous professionals. This segment provides commercial automobile liability and physical damage insurance to local, intermediate and long haul truckers, public transportation entities, and other types of specialty commercial automobile risks; incidental and related insurance coverages; inland marine coverages; management liability coverages, such as directors and officers liability insurance, fiduciary liability and coverages, employment practice liability, and for various classes of risks, including public and private businesses; and home business insurance products. The company's Property segment offers commercial property, cargo, hull, protection and indemnity, marine liability, inland marine, homeowners' and dwelling fire, and other property insurance products. Its Surety segment offers commercial surety bonds for medium to large-sized businesses; small bonds for businesses and individuals; and bonds for small to medium-sized contractors. The company also engages in various reinsurance coverages. It markets its products through branch offices, wholesale and retail brokers, carrier partners, and underwriting and independent agents. RLI Corp. was incorporated in 1965 and is headquartered in Peoria, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Intuit's Great SaaS Reset: Fired By AI Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish Target Shows Strengths, But Analysts Want to See More Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
